284620 — Kainos Medicine Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Kainos Medicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	80.1	-11,448	-16,225	-15,914	-15,239
Depreciation
Amortisation
Non-Cash Items	-124	3,396	7,920	1,781	-469
Unusual Items
Other Non-Cash Items
Changes in Working Capital	135	23.4	-1,700	1,574	210
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	91	-7,608	-9,195	-11,296	-14,221
Capital Expenditures	—	-1,221	-2,395	-2,465	-4,098
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-136	3,031	-3,358	5,250	13,153
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-136	1,811	-5,753	2,785	9,055
Financing Cash Flow Items	0	1,024	198	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0	25,775	14,667	9,342	-3,705
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-44.6	18,141	1,279	1,721	-8,615